Category: News
Rare Cancer Day
October 1 is Rare Cancer Day as proclaimed by the National Organization for Rare Disorders (NORD). The NORD website shares…
Suggested Reading - Graeber
Charles Graeber, The Breakthrough: Immunotherapy and the Race to Cure Cancer, Twelve, 2018. “Cancer kills millions of people every year…
Why Jan & Dean Meyer Gave $125,000 to the Cholangiocarcinoma Foundation, and why they hope others will too
“Cholangiocarcinoma sucks, it’s a tough, tough cancer. Being difficult to diagnose, often diagnosed in later stages, and having limited treatment options,…
University of Chicago Regional Symposium
Join us for an afternoon dedicated to the science of cholangiocarcinoma. The symposium will include presentations from the University of…
Cholangiocarcinoma Patients with a Specific Genetic Biomarker Now have a New Treatment Option
FDA grants approval to Merk & Co. for Keytruda (pembrolizumab) "The hope is that advanced genetic information will one day…
Immunotherapy
Our friends at Memorial Sloan Kettering have put together an excellent animation explaining Immunotherapy.
Five Biopharma Companies Headline Industry Night at Cholangiocarcinoma Foundation Annual Conference
ArQule, ASLAN Pharmaceuticals, Delcath Systems, Inc, InnoPharmax and Leap Therapeutics to Present Clinical Trial Concepts to International Research Network Truly,…
Saha Laboratory Opens Doors to Study Highly Lethal Cancer of the Bile Ducts
Cholangiocarcinoma Foundation Sees Great Promise in New Research Lab [SALT LAKE CITY, Utah (November 9, 2016) With the opening of…
Fall 2016 Newsletter
FROM OUR PRESIDENT This issue of the newsletter marks an exciting milestone for the Cholangiocarcinoma Foundation (CCF), as we are…
Cancer Moonshot
National Cancer MoonShot 2020 New Hope for Rare Cancers Before July of 1969, our nation thought that landing on the…